Mitochondrial Dysfunction Mediates Aldosterone-Induced Podocyte Damage: A Therapeutic Target of PPARγ
- 31 May 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 178 (5), 2020-2031
- https://doi.org/10.1016/j.ajpath.2011.01.029
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (30872803, 30971376)
- Natural Science Foundation of Jiangsu Province (BK2009046)
- National Institutes of Health (HL079453)
This publication has 46 references indexed in Scilit:
- Minireview: The PGC-1 Coactivator Networks: Chromatin-Remodeling and Mitochondrial Energy MetabolismMolecular Endocrinology, 2009
- Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing CellsOnline Journal of Public Health Informatics, 2008
- Insulin Resistance, Oxidative Stress, and Podocyte Injury: Role of Rosuvastatin Modulation of Filtration Barrier InjuryAmerican Journal of Nephrology, 2007
- Aldosterone induces epithelial-mesenchymal transition via ROS of mitochondrial originAmerican Journal of Physiology-Renal Physiology, 2007
- Identification of the HIV-1 gp41 Core-binding Motif in the Scaffolding Domain of Caveolin-1Online Journal of Public Health Informatics, 2007
- Podocyte as the Target for AldosteroneHypertension, 2007
- Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic ratAmerican Journal of Physiology-Renal Physiology, 2006
- Insulin resistance and atherosclerosisJCI Insight, 2006
- Podocyte Injury Underlies the Glomerulopathy of Dahl Salt-Hypertensive Rats and Is Reversed by Aldosterone BlockerHypertension, 2006
- The role of mitochondria in ageing and carcinogenesisClinical and Experimental Dermatology, 2006